Reithera
24 January 2025
Reithera and Sillajen Partnership Announced
Rome, Italy January 24th 2025 – ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.....
Phacilitate
22 January 2025
Phacilitate Awards Katherine High with the 2025 Lifetime Achievement Award at the Advanced Therapies Awards Ceremony in Dallas
London, UK, January 22, 2025 – Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with its prestigious Lifetime Achievement Award for 2025. Dr. High, who is now President of Therapeutics at AskBio, has had....
Catalent
21 January 2025
Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S.
January 21 2025 – SOMERSET, NJ – Catalent, Inc., a leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic collaboration with Galapagos NV (Euronext & NASDAQ: GLPG), a biotechnology company with operations in the U.S. and Europe, to support decentralized manufacturing for clinical studies....
Terumo BCT
14 January 2025
Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers
Lakewood, COLO. AND SANTA ANA, CALIF., January 14, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System. By using systems that work together, this collaboration offers an optimized workflow solution with a ready-to-use process, aimed at reducing the barriers in scaling T cell expansion.